Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Obducat receives pilot order valued at 2.6 MSEK

OBDUCAT AB (publ) subsidiary Obducat Technologies AB, a leading supplier of lithography solutions based on nanoimprint lithography (NIL), has received a pilot order related to the evaluation project that was communicated in January 2020. The customer is a European company active within photosensor technologies. The pilot order concerns the production of a larger test batch of optical components.  The order value amounts to approx. 2.6 MSEK. The order concerns a larger pilot production run of optical components produced by using Obducat proprietary NIL technology. Delivery is scheduled to

Wärtsilä plans to further optimise its European engine manufacturing footprint

Wärtsilä Corporation, Inside information, 14.7.2022 at 09:30 EESTWärtsilä plans to further optimise its European engine manufacturing footprint Wärtsilä plans to ramp down manufacturing in Trieste, Italy and to centralise its 4-stroke engine manufacturing in Europe to Vaasa, Finland. Ending the manufacturing in Trieste is expected to impact approximately 450 employees with potential redundancy. The estimated full annual cost savings are approximately 35 MEUR by 2025 and the associated transformation costs are expected to be approximately 130 MEUR, out of which the cash flow impact is

BioGaia’s result for second quarter to exceed market expectations

(Figures in brackets refer to the same period the previous year) BioGaia´s sales for the second quarter has been positively impacted by an increased demand mainly from the European market. Sales for the second quarter are preliminarily estimated at SEK 288 million (203), up 42%. Operating profit for the second quarter is preliminarily estimated at SEK 101 million (69), up 46%. BioGaia will publish the interim report for the second quarter on Friday, 22 July 2022 at 08:00 a.m., followed by a teleconference at 09:30 a.m. Latest press releases from BioGaia: 01.07.2022 BioGaia

Kelly Chen on board as new Head of Sales Asia Global Industries Marine at GF Piping Systems

Chen will focus on developing and implementing a commercial strategy to identify new business opportunities for the Swiss flow solutions provider in Asia, increasing customer proximity.In addition to a strong background in the marine industry, Kelly Chen brings with her a wide experience in sales management, business development, customer relationship management and in leading sales teams. She is excited about her new challenge of working in a global team of different cultures, "I look forward to build up a marine team for the Asian markets to strengthen GF Piping Systems' global setup and

Mycronic’s Board of Directors resolves to acquire the company’s own shares

Mycronic’s Board of Directors has resolved to utilize the authorization given by the Annual General Meeting 2022 to acquire the company’s own shares in accordance with the following:   1. Acquisition may not exceed 113,900 shares in the company   2. Acquisition of shares in the company may only be made on Nasdaq Stockholm   3. Acquisition of shares on Nasdaq Stockholm may only take place at a price within the price range recorded on the Nasdaq Stockholm at any given time   4. The payment for the shares shall be made in cash   5. The resolution may be used

Metso Outotec wins order for crusher upgrades in India

Metso Outotec Corporation’s press release on July 14, 2022, at 09:00 a.m. EESTMetso Outotec has signed an agreement with Larsen & Toubro Limited to supply four Symons™ cone crushers for an iron ore crushing and screening plant to National Mineral Development Corporation (NMDC) at Kirandul complex in Chhattisgarh, in the region of Central India. The value of the order is not disclosed, and it has been booked in Minerals segment Q2/2022 orders received. Crushing has one of the biggest environmental impacts in mining and aggregate operations. It is also one of the most critical ones. The

SAGAX INVESTS SEK 623 MILLION THROUGH 6 TRANSACTIONS

Sagax has through six separate transactions acquired 18 properties for the equivalent of SEK 623 million. The properties comprise a lettable area of 66,900 square metres, mainly consisting of premises for warehousing and light industrial purposes. The annual rental income amounts to the equivalent of SEK 60 million. The occupancy rate is 95% and the average remaining lease term is 3.9 years. Closing for the equivalent of SEK 471 million has taken place. Closing for the remaining SEK 152 million is expected to take place during the third and fourth quarter of 2022. The acquisitions will

Fiskars to publish its Half-year Financial Report for January-June 2022 on July 28, 2022

Fiskars CorporationPress ReleaseJuly 14, 2022 at 9:00 EESTFiskars to publish its Half-year Financial Report for January-June 2022 on July 28, 2022 Fiskars Corporation will publish it Half-year Financial Report for January-June 2022 on July 28, 2022 at approximately 8:30 a.m. (EEST). The Half-year Financial Report will be available on the company's website www.fiskarsgroup.com after publication.WebcastA webcast on the second quarter results will be held on July 28, 2022 at 11:00 a.m. (EEST). It will be held in English and can be followed at: https://fiskars.videosync.fi/q2-2022

Interim Report January–June 2022

Second quarter · Order intake amounted to SEK 1,203 (1,002) million, an increase of 20 percent · Net sales increased 20 percent to SEK 1,273 (1,064) million. Based on constant exchange rates, net sales increased 10 percent · EBIT amounted to SEK 224 (241) million and the EBIT margin was 18 (23) percent  · Earnings per share were SEK 1.79 (1.84) January–June · Order intake amounted to SEK 2,644 (2,030) million, an increase of 30 percent · Net sales increased 2 percent to SEK 2,408 (2,355) million. Based on constant exchange rates, net sales decreased 6 percent ·

Report for the second quarter 2022

Financial and operating highlights 2Q22 (2Q21 in brackets): · Operating revenues were NOK 2 386 million (NOK 1 611 million) · EBITDA was NOK 562 million (NOK 313 million) · EBIT was NOK 334 million (NOK 80 million) · Net result after tax was NOK 161 million (NOK -11 million) Segment highlights 2Q22 (2Q21 in brackets): Renewable Energy · EBITDA NOK 502 mill. (NOK 197 mill.) · Continued high power prices · Fäbodliden 2 continues towards construction in 2023 · High development activity in all business areas · Establishment of Hvitsten AS, a EUR 480 million

CS MEDICA A/S: CEO Lone Henriksen buys shares in the Company

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CEO of the Company, Lone Henriksen, has acquired 10 470 shares in CS MEDICA through several transactions at an average price of 7,33 DKK, amounting to a total value of 76 779,76 DKK.CEO of CS MEDICA, Lone Henriksen, has purchased 10 470 shares in the open market at an average price of 7,33 DKK per share, corresponding to a total purchase of 76 779,76 DKK. The transactions have been disclosed to the Danish financial supervisory register. Following the transaction, Lone owns 4 065 441 CS MEDICA shares.

Nexam Chemical Holding AB (publ) Interim Report 1 January – 30 June 2022

Turbulent quarter with several bright spotsSecond quarter at a glance Significant events: · Sales decreased by 7% in the quarter, Performance Masterbatch + 23% and Performance Chemical, -32%, compared with the corresponding quarter in 2021. · Recruited Borys Schaffran, based in the USA, as responsible for sales development in North America. · The first part of the innovation center in Lomma completed and in operation after the summer. Financials: · Net sales during quarter amounted to SEK 55,417,000 (59,664,000). · The operating profit before depreciation (EBITDA)

Orexo Interim Report Q2 2022

Good tailwind in the financial development Q2 2022 highlights · Total net revenues of SEK 147.8 m (142.8) · EBITDA of SEK -32.5 m (-41.1)  · Net earnings of SEK -35.8 m (-73.7) · US Pharma segment (ZUBSOLV® US) net revenues of SEK 139.6 m (126.0), in local currency USD 14.2 m (15.0), US Pharma EBIT of SEK 77.2 m (61.6) · Cash flow from operating activities of SEK 14.5 m (-20.9), cash and invested funds of SEK 467.7 m (679.7) · Earnings per share before and after dilution amounted to -1.04 (-2.15) · Christine Rankin and Michael J Matly were elected as Board members

SBB, Interim Report January – June 2022: Strong cashflow and focus on core business

SAMHÄLLSBYGGNADSBOLAGET I NORDEN AB (PUBL): INTERIM REPORT JANUARY – JUNE 2022 IN BRIEF: · Rental income increased by 34 percent to SEK 3,709m (2,776) · The operating surplus increased by 30 percent to SEK 2,443m (1,877). · Cashflow from operating activities before changes in working capital increased to SEK 1,789m (1,139). · Profit before tax decreased to SEK 860m (10,059), of which: ·  Profit from property management is included in the amount of SEK 1,299m (1,442). The profit from property management includes costs for early repayment of loans and other items affecting

Interim report for Q2 2022

Continued growth in the licensing business and in our product portfolioSecond quarter (April-June 2022) · Revenues amounted to SEK 59.9 (46.0) million, an increase of 30%. Adjusted for currency, revenues increased by 13%. · EBITDA amounted to SEK -3.8 (1.8) million, with an EBITDA margin of -6.4% (4.0). · Operating profit/loss amounted to SEK -14.8 (-10.0) million, a decrease of SEK -4.9 million. · Net profit/loss for the period amounted to SEK -13.7 (-12.0) million. · Losses per share amounted to SEK -0.39 (-0.36). · Cash flow from operating activities amounted to SEK -

Wallenstam’s interim report Jan 1–Jun 30, 2022: Well-equipped with a strong balance sheet

Hans Wallenstam, CEO, and Susann Linde, CFO and Head of Investor Relations, comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CEST) at the latest. An audiocast in English with Susann Linde will take place at 09.30 (CEST) at www.financialhearings.com. The presentation is available at www.wallenstam.se/filmsandpresentations before 09.30 (CEST). January 1–June 30, 2022 · The equity/assets ratio amounted to 47 percent and the loan-to-value ratio was 43 percent. · The net asset value per share amounted to SEK 60.10 (57.30). The goal

OKEA ASA – Initiation of share acquisitions by primary insiders

Trondheim, 14 July 2022  Primary insiders of OKEA ASA (OSE:OKEA) have mandated a third party to carry out a collective share purchase for an amount of up to approximately NOK 900,000. The collective share purchase will start today and is expected to be terminated on 15 July 2022 at the latest. The share acquisitions are made in accordance with the resolution from the company’s general meeting 12 May 2022 on additional compensation to the company's board of directors with an obligation to purchase shares (item 12). The shares will be subject to a 12-month lock-up period from the date of

Storebrand Boligkreditt AS: Interim Report Q2 2022

Storebrand Boligkreditt AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q2 2022 result and Balance sheet statement, please refer to the Storebrand Group Q2 2022 interim report. Storebrand Boligkreditt AS's interim report for Q2 2022 is attached.  This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Storebrand Livsforsikring AS: Interim Report Q2 2022

Storebrand Livsforsikring AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q2 2022 result and Balance sheet statement, please refer to the Storebrand Group Q2 2022 interim report. Storebrand Livsforsikring AS's interim report for Q2 2022 is attached.  This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Interim report January-June 2022

Collector AB publishes the interim report for the period January-June 2022.SECOND QUARTER OF 2022 (COMPARED TO THE SECOND QUARTER OF 2021) · The loan portfolio amounted to SEK 40,795 million (34,722) · Total income amounted to SEK 751 million (665) · The C/I ratio amounted to 27.6% (31.6) · The credit loss level amounted to 2.4% (2.7) · Operating profit amounted to SEK 302 million (230) · Net profit amounted to SEK 237 million (181) and earnings per share amounted to SEK 1.11 (0.83) · Return on equity amounted to 15.5% (13.7) · The CET1 ratio amounted to 13.4% (13.

STOREBRAND ASA: Results for the 2nd Quarter 2022

Resilient Business Model in Turbulent Markets, Share Buybacks to Commence.· Group profit[1] of NOK 577m, operating profit of NOK 705m · Solvency II ratio 195% · Start of NOK 500m share buyback program · 14% overall growth in insurance portfolio premiums (y/y) · Rating upgrade by S&P Global Ratings to 'A' "By the conclusion of first half of 2022, the world is still facing geopolitical and financial turmoil. Inflation is rising and markets are volatile. The economic activity in Norway and Sweden is high and interest rates are increasing. Higher interest rates give better

KONE lowers full year sales and adjusted EBIT outlook and provides preliminary key figures for the second quarter

KONE Corporation, stock exchange release, July 14, 2022 at 8.30 am EEST KONE lowers full year sales and adjusted EBIT outlook and provides preliminary key figures for the second quarter The demand environment remained healthy in most areas during the second quarter and our services business development continued to be strong. However, KONE’s second quarter net sales and adjusted EBIT were significantly impacted by the COVID-19 lockdowns in China which resulted in China’s net sales declining by close to 40% at comparable currencies. Operations in China have been fully ramped up in June

Nanoform and Pharmanovia to breathe new life into iconic medicines

Press release Nanoform Finland Plc July 14[th], 2022 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform and Pharmanovia to breathe new life into iconic medicines Helsinki, Finland – Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has partnered with Pharmanovia, a fast-growing specialty pharma business with a portfolio of over 20 branded drugs in 140 markets. The new strategic partnership aims to add value to branded prescription medicines. Pharmanovia will look to apply Nanoform’s proprietary nanoparticle

There are no items matching the current filter
There are no more items matching the current filter
Back to top